Company: DVAX
Filing Date: 2025-04-03
Form Type: PREC14A
Source: 0000930413-25-001153
Chunk: 94

Company: DYNAVAX TECHNOLOGIES CORP
Filing Date: 2025-04-03
Form: PREC14A
Chunk 94
---
 to allow stockholders to better understand and assess each particular company’s compensation practices and
pay ratio disclosures.

Neither the Compensation Committee nor our management used our CEO
Pay Ratio measure in making compensation decisions.

| 74 |

ITEM 402(V) PAY VERSUS PERFORMANCE

The disclosure included in this section is prescribed by SEC rules
and does not necessarily align with how the Company or the Compensation Committee view the link between the Company’s performance
and NEO pay. For additional information about our pay-for-performance philosophy and how we align NEO compensation with Company performance,
refer to the “Compensation Discussion and Analysis” beginning on page 43.

Required Tabular Disclosure of Pay Versus Performance

The amounts set forth below under the headings “Compensation
Actually Paid to PEO” and “Average Compensation Actually Paid to Non-PEO NEOs” have been calculated in a manner consistent
with Item 402(v) of Regulation S-K. Use of the term “compensation actually paid” (“CAP”) is required by the SEC’s
rules and as a result of the calculation methodology required by the SEC, such amounts differ from compensation actually received by the
individuals and the compensation decisions described in the “Compensation Discussion and Analysis” section beginning on page
43.

| Year 
 (a)  |      |     | Summary         
 Compensation    
 Table Total for 
 PEO ($)(1&2)    
 (b)             |           |     | Compensation  
 Actually Paid 
 to            
 PEO ($)(1&3)  
 (c)           |           |     | Average         
 Summary         
 Compensation    
 Table Total for 
 Non-PEO         
 NEOs            
 ($)(1&2)        
 (d)             |           |     | Average       
 Compensation  
 Actually Paid 
 to            
 Non-PEO       
 NEOs          
 ($)(1&3)      
 (e)           |           |     | Value                 
 of Initial Fixed $100 
 Investment Based On:  
 Total                 
 Shareholder           
 Return ($)(4)         
 (f)                   |        |     | Peer          
 Group         
 Total         
 Shareholder   
 Return ($)(4) 
 (g)           |        |     | Net         
 Income      
 (thousands) 
 ($)(5)      
 (h)         |         |     | HEPLISAVB   
 Product     
 Revenue     
 (thousands) 
 ($)(6)      
 (i)         |         |
|:-----|-----:|:----|:----------------|----------:|:----|